Cargando…
MIA is a potential biomarker for tumour load in neurofibromatosis type 1
BACKGROUND: Neurofibromatosis type 1 (NF1) is a frequent genetic disease characterized by multiple benign tumours with increased risk for malignancy. There is currently no biomarker for tumour load in NF1 patients. METHODS: In situ hybridization and quantitative real-time polymerase reaction were ap...
Autores principales: | Kolanczyk, Mateusz, Mautner, Victor, Kossler, Nadine, Nguyen, Rosa, Kühnisch, Jirko, Zemojtel, Tomasz, Jamsheer, Aleksander, Wegener, Eike, Thurisch, Boris, Tinschert, Sigrid, Holtkamp, Nikola, Park, Su-Jin, Birch, Patricia, Kendler, David, Harder, Anja, Mundlos, Stefan, Kluwe, Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224593/ https://www.ncbi.nlm.nih.gov/pubmed/21726432 http://dx.doi.org/10.1186/1741-7015-9-82 |
Ejemplares similares
-
Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin
por: Kolanczyk, Mateusz, et al.
Publicado: (2008) -
Double NF1 Inactivation Affects Adrenocortical Function in NF1Prx1 Mice and a Human Patient
por: Kobus, Karolina, et al.
Publicado: (2015) -
Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors
por: Park, Su-Jin, et al.
Publicado: (2013) -
Multiscale, Converging Defects of Macro-Porosity, Microstructure and Matrix Mineralization Impact Long Bone Fragility in NF1
por: Kühnisch, Jirko, et al.
Publicado: (2014) -
Osteopoikilosis and multiple exostoses caused by novel mutations in LEMD3 and EXT1 genes respectively - coincidence within one family
por: Baasanjav, Sevjidmaa, et al.
Publicado: (2010)